| Send2Press.com • Today is Sunday, February 12, 2012 | A Member of the Neotrope News Network |  |
|
|
NEWS ARCHIVES : U.S. and World News :
Medical :
Surgery and Neurotechnology
News
|
Press Release:
Global Medical Research Announces Breakthrough Technology to Prevent Post-Surgical Adhesions
The base technology has been in development for several years at the University of North Texas Health Science Center under the direction of Dr. S. Dan Dimitrijevich, Director of the Tissue and Cell and Tissue Engineering Division of the Cardiovascular Research Institute. With the acquisition of exclusive Worldwide Licensing Rights for i-TEMP(tm), GMR has also undertaken the financial responsibility for the commercialization steps that include process development and product testing. In order to maintain a proprietary position, information about the device is limited, but what is evident from the company's research is that the efficacy in prevention of adhesions is greater than ninety percent. In addition, i-TEMP(tm) has an excellent shelf life, is easy to handle, can be delivered laproscopically, and is completely bio-absorbed after application. GMR also maintains that the materials that would be used for the manufacture of i-TEMP(tm) have been approved by the FDA for use in other biomedical devices that are FDA approved and currently being used in humans. While the research and development work continues to be performed by Dr. S. Dan Dimitrijevich and his team at UNTHSC, all contractual negotiations and other aspects of commercialization are conducted at GMR's corporate headquarters in Winter Park, Florida. i-TEMP(tm) is anticipated to save billions of dollars in health care costs associated with re-do surgeries to resolve Adhesion Related Disorders (ARD) which result in extended hospital stays, and could possibly reduce some of the 2,500 adhesion related deaths each year. i-TEMP(tm) is expected to improve the quality of life for a multitude of surgical patients that include an increasing number of women undergoing hysterectomies, C-sections or suffering from endometriosis. GMR's Medical Advisory Board currently includes 5 highly qualified individuals and is expected to add two additional members. Presently the Board is chaired by Dr. Kevin Accola (Cardiovascular Surgeon, Founder/Member). The other Medical Advisory Board Members are: Dr. Dan Dimitrijevich (Director of Research/Inventor/Founder), Dr. Joseph Allgeier (Director of Medical Education at Florida Hospital), Dr. Albert Olivencia-Yurvati (Associate Professor of Cardiovascular Surgery, UNTHSC), and Dr. David Wiseman (founder of the International Adhesion Society and a recognized leader in the testing and evaluation of adhesion prevention). GMR is maintaining close contact and discussions with its regulatory consultants in order to assure that all FDA criteria are being observed. GMR has been approached by hedge funds, distributors, manufacturers, proposing partnerships, the sale of the devise and/or joint ventures to manufacture and distribute what is likely to be millions of i-TEMP(tm)s annually. For additional information regarding the severity of ARD visit the following web sites: www.adhesions.org or www.adhesions.org.uk. More information about Global Medical Research, LLC www.gmrllc.com. CONTACT(S): Mr. Michael Garfield, CEO Mr. Harvey Berger, Exc. VP / Dir. Of Oper. of Global Medical Research +1-407-599-5300 +1-407-599-2255 Fax
NEWS SOURCE: Global Medical Research, LLC
Send2Press® is the originating wire service for this story. Terms of Use. © Global Medical Research, LLC. All trademarks acknowledged.
THE CONTENT OF THE ABOVE PRESS RELEASE WAS PROVIDED BY THE NEWS SOURCE (Global Medical Research, LLC), WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT THIS WEBSITE.
Journalist Resources:
Download original press release as issued including media contact information for Global Medical Research, LLC.
Additional News Releases on Similar Topics:
|
Subscribe to Send2Press®
Daily News Releases by E-Mail
Follow Send2Press on Social Sites: 
Additional News from
Global Medical Research, LLC : » Global Medical Research Announces Breakthrough Technology to Prevent Post-Surgical Adhesions
|
|||||||||||||||||||||||
View our news channels by industry topics, by U.S. States, or by selected U.S. Cities:
|
Terms of Use and License
This "article format" version of the issued press release is Copr. © 1983-2012 Neotrope/Send2Press. You may freely link to this article version of the press release or may use the release text as the basis for an original article or news posting. If the content is copied verbatim via a scraping or copy/paste method, the news item must be properly "attributed" to Send2Press® Newswire as the originating wire service for this story (may not be posted on ANY site selling/offering SEO or PR services, newswire services, or adult content!). |
DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the source. The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this website) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
REFERENCES: Global Medical Research Announces Breakthrough Technology to Prevent Post-Surgical Adhesions, i-TEMP, Global Medical Research, LLC, adhesions, surgery, obgyn, anti-adhesions, biotech, adhesion prevention, medical devices, dr. dan dimitrijevich, Michael Garfield, Harvey Berger, Kevin Accola, President Clinton, Bill Clinton Surgery, procedure , press release, Feb 25, 2005. |
|
THIS PAGE MEDIA READS (by media and public, as of today): 10062 times (4 today, 4 this week, 18 this month, 65 this year)
Site Design and Content is Copr. © 1983 - 2011 Neotrope® - All rights reserved. Send2Press® is a reg. trademark and service mark of NEOTROPE.
Press Release Writing | About Send2Press | Meet Our Staff | Contact Us | Our Services | Help Desk | Legal | Privacy | How-To Articles | RSS Feeds | Journalist Tools | Client eMediaKits | Headline Feeds | Podcast | PR News Channels | Daily News Desk | Success Stories | PRTRax™ Reader Tracking | Targeted News Distribution | Internet Marketing Services | Order PR Services | Terms of Service (TOS)